Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats
Other Titles: Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats
Author: Stringer, A.
Gibson, R.
Logan, R.
Bowen, J.
Yeoh, A.
Keefe, D.
Citation: Cancer Biology and Therapy, 2008; 7(12):1919-1925
Publisher: Landes Bioscience
Issue Date: 2008
ISSN: 1538-4047
Statement of
Andrea M Stringer, Rachel J Gibson, Richard M Logan, Joanne M Bowen, Ann SJ Yeoh and Dorothy MK Keefe
Abstract: OBJECTIVES: Chemotherapy-induced diarrhea (CID) is a well recognized side effect of cancer treatment. However, the pathophysiology behind this debilitating side effect remains unclear. Irinotecan causes cholinergic and delayed onset diarrhea in patients, in which beta-glucuronidase produced by gut bacteria is thought to be involved. RESULTS: Diarrhea occurred, as expected, following irinotecan treatment. beta-glucuronidase expression increased in the jejunum and colon. Faecal flora changed quantitatively after treatment also, with increases in E. coli, Staphylococcus spp. and Clostridium spp. (all beta-glucuronidase producing) and decreases in Lactobacillus spp., Bifidobacterium spp. (both beneficial bacteria), and Bacteroides spp. (beta-glucuronidase producing, major component of intestinal flora). METHODS: Rats were treated with 200 mg/kg irinotecan and killed at various time points up to 72 h. Rats were monitored for diarrhea. Sections were stained for beta-glucuronidase expression, and faecal DNA was analysed using real time PCR. CONCLUSIONS: Irinotecan-induced diarrhea may be caused by an increase in beta-glucuronidase producing bacteria. However, the increase in bacteria may also be caused by irinotecan, further exaggerating the toxicity of the drug and emphasising the need for these specific bacteria to be therapeutically targeted for successful treatment regimens to be accomplished.
Keywords: Gastrointestinal Tract
Escherichia coli
Antineoplastic Agents, Phytogenic
Gene Expression Regulation, Enzymologic
Description: © 2008 Landes Bioscience
DOI: 10.4161/cbt.7.12.6940
Description (link):
Appears in Collections:Aurora harvest
Dentistry publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.